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S U M M A R Y
Emerging and re-emerging zoonoses are a signiﬁcant public health concern and cause considerable
socioeconomic problems globally. The emergence of severe acute respiratory syndrome (SARS), highly
pathogenic avian inﬂuenza (HPAI) H5N1, avian inﬂuenza H7N9, and severe fever with thrombocytopenia
syndrome (SFTS), and the re-emergence of rabies, brucellosis, and other zoonoses have had a signiﬁcant
effect on the national economy and public health in China, and have affected other countries.
Contributing factors that continue to affect emerging and re-emerging zoonoses in China include social
and environmental factors and microbial evolution, such as population growth, urbanization,
deforestation, livestock production, food safety, climate change, and pathogen mutation. The Chinese
government has devised new strategies and has taken measures to deal with the challenges of these
diseases, including the issuing of laws and regulations, establishment of disease reporting systems,
implementation of special projects for major infectious diseases, interdisciplinary and international
cooperation, exotic disease surveillance, and health education. These strategies and measures can serve
as models for the surveillance and response to continuing threats from emerging and re-emerging
zoonoses in other countries.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Economic globalization promotes globalization of capital,
technology, labor, and commodities, and also contributes to the
globalization of emerging infectious diseases. The world is
becoming a global community, and a public health event in one
geographic region or nation often affects the health and economy
beyond that region, sometimes even globally. China has 34
provincial-level administrative regions and 2856 counties, which
are covered by urban and rural health systems. The urban health
system comprises hospitals of three different levels, disease
control and prevention centers, and health authorities, while the
rural health system includes county hospitals, health and epidemic
prevention stations, and maternal and child health stations. As
China has one fourth of the global population and has close ties
with other countries through travel and trade, public health events
in the country can have an important impact on distant* Corresponding author. Tel.: +86 931 8342837; fax: +86 931 8340977.
E-mail addresses: xingquanzhu1@hotmail.com, xingquanzh@scau.edu.cn
(X.-Q. Zhu).
http://dx.doi.org/10.1016/j.ijid.2014.04.003
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).populations in other countries, and the control of infectious
diseases in China implies the control of infectious diseases in the
world to a large extent.1 China is a major contributor to the spread
and control of infectious diseases in the world. For example, the
ﬁrst case of severe acute respiratory syndrome (SARS) arose in
2002 in Guangdong, China, and was transmitted to Hong Kong, and
then to other countries.2 The goose/Guangdong/1/1996 H5N1 virus
found in a goose farm in southern China in 1996 is considered the
precursor of the currently circulating highly pathogenic avian
inﬂuenza (HPAI) H5N1 viruses in more than 60 countries.3
Most of these emerging infectious diseases are zoonoses, or
zoonotic diseases, a group of diseases and infections naturally
transmitted from vertebrate animals to humans. These diseases
have a negative impact on economic development and human
health in both developing and industrial countries.4 Of the 1415
species documented as pathogenic to humans in 2001, 61%
originated from animals or animal products, and 70% of these
zoonotic infections originated from wildlife.5 In this review, we
summarize the major emerging and re-emerging zoonoses and
contributing factors, and the strategies and measures being used to
deal with the challenges of these diseases in China.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Q. Liu et al. / International Journal of Infectious Diseases 25 (2014) 65–72662. Major emerging and re-emerging zoonoses in China
The Chinese government established an infectious diseases
reporting system in the 1950s. Since then, the number of notiﬁable
diseases has increased from 15 to 41 (in 2011), with emerging
zoonoses accounting for over 50% (Table 1); in 2011, 18% of cases
and 36% of deaths resulted from emerging zoonoses.6 SARS, HPAI,
rabies, Japanese encephalitis, brucellosis, and schistosomiasis
japonica are considered major emerging zoonoses in China.7
2.1. Severe fever with thrombocytopenia syndrome (SFTS)
In May 2007, a life-threatening disease, characterized by the
sudden onset of fever, thrombocytopenia, and leukopenia,
designated severe fever with thrombocytopenia syndrome (SFTS),
was ﬁrst described in several provinces in central and northeast
China.8 In 2009, the novel bunyavirus, also named SFTS virus
(SFTSV), belonging to the family of Bunyaviridae, genus Phlebovirus,
was identiﬁed as the causative agent of this disease.9
SFTS has been found in the provinces of Henan, Hubei,
Shandong, Anhui, Liaoning, and Jiangsu, and has often occurred
in spring and summer, especially in hilly regions.9 People are
generally susceptible, especially those who live or work in the hills,
mountains, and forests. Some SFTS patients have reported that
they had seen or been bitten by ticks before the onset of their
illness, and Haemaphysalis longicornis has been found infected with
SFTSV.10 Speciﬁc antibody to SFTSV antigens has been detected in
animals in endemic regions.11 SFTSV is therefore proposed to be
transmitted by contact with animals and/or vectors.
The virus is also frequently detected in urine, feces, or throat
specimens of patients, and thus can be transmitted from person to
person through contact with the blood or secretions of patients.12
Several outbreaks of family clusters of SFTS have also provided
evidence of person-to-person transmission.8,13 Recently, a novelTable 1
Notiﬁable zoonotic diseases in China in 2011
Disease Pathogen Category
of diseasea
Plague Yersinia pestis A
Cholera Vibrio cholerae A
Severe acute respiratory
syndrome (SARS)
SARS coronavirus B
Acquired immunodeﬁciency
syndrome (AIDS)
Human
immunodeﬁciency
virus (HIV)
B
Hepatitis E Hepatitis E virus B
Highly pathogenic avian
inﬂuenza (HPAI)
Highly pathogenic
avian inﬂuenza
virus (HPAI virus)
B
H1N1 inﬂuenza Inﬂuenza A virus
subtype H1N1
B
Hemorrhagic fever with renal
syndrome (HFRS)
Hantaan virus B
Rabies Rabies virus B
Japanese encephalitis Japanese
encephalitis
virus (JEV)
B
Dengue fever Dengue virus B
Anthrax Bacillus anthracis B
Tuberculosis Mycobacterium
tuberculosis
B
Brucellosis Brucella B
Leptospirosis Leptospira B
Schistosomiasis Schistosoma japonicum B
Typhus Orientia tsutsugamushi C
Kala-azar Leishmania donovani C
Hydatid disease Echinococcus granulosus,
E. multilocularis
C
a The infectious diseases in China are divided into three categories (A, B, and C)
according to their transmission modes, speed, and hazard to humans.bunyavirus was detected in two patients with a history of tick bite
in the USA, whose clinical features were similar to those of SFTS,
suggesting that SFTS has become an emerging zoonosis world-
wide.14
2.2. SARS
SARS is an emerging zoonosis caused by a new type of
coronavirus in the world. The earliest cases of SARS occurred in
Guangdong Province in November 2002, spread rapidly to Hong
Kong and other provinces in China, and then from Hong Kong to
other countries. China reported 5327 of 8098 (66%) cases of SARS
and 349 of 774 (45%) deaths during the 2003 outbreak.2 The origin
of the virus was never deﬁnitely conﬁrmed, but coronavirus has
been isolated from palm civets, raccoon dogs, ferret badgers, cats,
and bats, which might serve as the animal reservoirs or infection
sources for humans.15–18
2.3. HPAI H5N1
Since the ﬁrst identiﬁcation of HPAI H5N1 virus in Guangdong
in 1996, the disease has been found in poultry, including chickens,
ducks, and geese, in 16 provinces of China, and in wild aquatic birds
from Qinghai and Tibet.19 There were 36 conﬁrmed human cases
infected with H5N1 and 25 deaths during 2005–2011 in China.20
HPAI is spread by direct contact with infected birds or indirect
contact with the virus contaminants, and humans are mainly
infected by contact with infected chickens. Wild birds play an
important role as long-distance animal reservoirs of HPAI virus.21
2.4. Avian inﬂuenza H7N9
In March 2013, a novel reassortant avian-origin inﬂuenza A
(H7N9) virus was isolated from three patients who died following a
severe lower respiratory tract disease. One of these patients was
from Anhui Province and the other two from Shanghai City.22 Up to
October 2013, China had reported a total of 136 cases infected with
H7N9 virus in eight provinces and two municipalities, of which 45
were fatal, showing a fatality rate of 33.1%.23
Surveillance in live-poultry markets demonstrated that
pigeons, chickens, and ducks were all positive for H7N9 virus,
but did not present any clinical symptoms.24 Several H7N9
patients reported that they had been in close contact with birds
at wet markets, or had consumed poultry from wet markets,
showing the zoonotic introduction of H7N9 virus from avian
species to humans.24,25 Avian species carrying H7N9 virus,
including their secretions and excretions, may be the source of
infections. The virus may be transmitted through the respiratory
tract or by exposure to the secretions or excretions of the infected
birds. Direct exposure to the virus can also result in infection.26
Although there is no conﬁrmed evidence of human-to-human
transmission, H7N9 virus poses a potentially high risk to humans,
as the virus can bind to both human-type and avian-type
receptors.27,28
2.5. Rabies
Rabies is a fatal zoonotic disease of almost all mammalian
species, with a history of more than 2000 years in China. Since the
1950s, there have been three rabies epidemic peaks in China.29 The
ﬁrst occurred in the mid-1950s resulting in up to 1900 annual
deaths; the second peak occurred in the early 1980s with annual
deaths of 5537; the third peak occurred in the early 2000s with
annual deaths of 2400, and up to 3300 in 2007. In 1996, only 21
provinces including 98 counties reported rabies, but the number
reached 23 provinces including 984 counties in 2007.30 During the
Figure 1. Reported cases of the four major zoonotic diseases – rabies, Japanese encephalitis, schistosomiasis japonica, and brucellosis – in China during 2003–2011. The data
were derived from epidemic information of notiﬁable infectious diseases in China. The brucellosis cases are expressed as 10% of the real incidences, and the cases of the other
three diseases are expressed as the actual incidences. The number of cases of schistosomiasis japonica was not available for the year 2003, because the disease was ﬁrst
considered a notiﬁable disease in 2004.
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high level of 2000 annual cases, with another peak reached in 2007
of 3300 cases (Figure 1). The high incidence of rabies is due to low
vaccination coverage and a high population density of cats and
dogs. Domestic and stray dogs play an important role in the
transmission of rabies in China, with 85–95% of human rabies cases
resulting from dog bites.31,32
2.6. Japanese encephalitis
Japanese encephalitis is an emerging vector-borne disease in
South and East Asia, including China. It is estimated that three
billion people live in the endemic regions, and the annual incidence
is approximately 30 000–50 000 cases worldwide.33 In China,
Japanese encephalitis has spread to all of the provinces, except
Xinjiang and Qinghai, and there were 39 805 cases and 1876
deaths reported during the last 10 years, probably due to
population growth, climate change, pig rearing, and the lack of
vaccination surveillance (Figure 1). Japanese encephalitis virus
(JEV) is transmitted by the mosquito Culex tritaeniorhynchus in
northern China, and Culex pipiens quinquefasciatus in southern
China.34 Water birds, especially herons and egrets are the main
animal reservoirs, and pigs are important ampliﬁer hosts, from
which JEV can be transmitted to humans and other vertebrates by
the bites of mosquitoes.35
2.7. Brucellosis
Brucellosis is distributed worldwide, particularly in developing
countries, with an annual occurrence of more than 500 000 cases.36
In China, human brucellosis was epidemic in the mid-1950s and
1970s, and a substantially decreased incidence was observed in the
mid-1990s.37 However, the disease has re-emerged rapidly during
the past 10 years, from 6448 new cases in 2003 to 38 151 in 2011,
possibly due to frequent market circulation and a lack of disease
quarantine (Figure 1). Humans are usually infected via direct
contact with infected animals, by eating or drinking contaminated
animal products, or by inhaling airborne agents.38
2.8. Schistosomiasis japonica
Schistosomiasis japonica remains a major public health
problem in China, although the number of human cases of
schistosomiasis reached an historical low of 694 788 by 2000, due
to the implementation of integrated control strategies.39 However,the disease re-emerged in 2001, and there were 843 011 infected
people, including 1114 acute cases and 24 441 advanced cases by
2003. There are 65 million people at risk of infection, and 74 000
infected cattle and a snail-infested area of 3787 km2.40 A total of
3145 new cases of human schistosomiasis were reported in 2005,
and this increased to 4483 in 2011, probably resulting from large
population movements and changing ecology. Bovines, particular-
ly water buffaloes (Bubalus bubalis), play an important role in the
transmission of the disease in China, while other animals, such as
rats, dogs, pigs, sheep, and goats may contribute only minimally to
overall transmission of the disease.41
3. Important factors contributing to emerging and re-
emerging zoonoses
The factors contributing to emerging and re-emerging zoonoses
are complicated and include microbial evolution and social and
environmental factors. Microbial evolution is the intrinsic factor
that leads to the emergence of new pathogens, and social and
environmental factors are external factors, including population
growth, mobility, and urbanization, and environmental changes
such as agriculture and livestock production, deforestation, and
climate change. These have all had important effects on emerging
and re-emerging zoonotic diseases in China.
3.1. Population growth
China is the most populous country in the world, with1.3 billion
people on land of 9.6 million square kilometers – approximately
20% of the total world population living on 6.7% of the world land.
The average population density is 130 people per square kilometer,
with an uneven distribution of over 400 in the eastern coastal
region, 200 in the central region, and less than 10 in the western
region.42 About 16 million babies are born every year; the
population is still increasing annually by 0.57% and will reach
1.5 billion by 2033.43 The increased susceptible population will
increase the potential for disease transmission, and increased
population density can directly contribute to the spread of
respiratory diseases, as occurred in the SARS outbreak in 2003.44
The number of older people is also growing in China. The
percentage of the population aged over 60 years is now about 10%,
and will reach 14.8% in 2015, i.e. up to 200 million. Aging is related
to an increased susceptibility to some zoonotic diseases; the
incidence of active pulmonary tuberculosis in individuals aged
over 60 years is three times the average incidence in China.45 In
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and those populations receiving immunosuppressive therapy are
susceptible to opportunistic pathogens. For example, Toxoplasma
gondii is an important opportunistic pathogen associated with
malignant disorders and HIV patients.46,47
3.2. Urbanization
In addition to rapid population growth, China is rapidly
becoming more urbanized. By the end of 2010, China had a total
urban population of 665 million, accounting for 50% of the total
population; this is expected to reach around 70% by 2035,
surpassing the average in the world.48 This massive urbanization
has signiﬁcant public health implications, increasing the occur-
rence of emerging and re-emerging zoonoses transmitted by water
or air, as well as those diseases transmitted through animals or
insects, due to the poor healthcare systems and inadequate
infrastructure.48
Accumulated garbage provides food and habitats for rodents
and other stray animals, and inadequate water supplies make it
necessary to store water in containers, which will become an ideal
habitat for mosquito larvae. These factors contribute to emerging
and re-emerging zoonotic diseases related to arthropods and
rodents, such as Japanese encephalitis, dengue fever, and epidemic
hemorrhagic fever.49
Urbanization provides opportunities for rural migrants, includ-
ing higher salaries and improved health conditions. Unfortunately,
not all people can ﬁnd a satisfying job in the city, due to low
educational levels and poor professional skills. Because of the
commercialization of blood and blood products in China, the sale of
plasma by poor people has become a popular way of making a
living.50 The reused needles and inadequately sterile equipment
facilitate the transmission of HIV through blood and blood
products.51
Urbanization also promotes population movement and migra-
tion. Most people are from rural areas, but work in urban
environments, hence regularly travelling between the two sites.
Due to ﬁnancial constraints and overcrowded and unsanitary
living conditions, these people are more vulnerable to infectious
diseases, especially HIV and viral hepatitis. Additionally, their
mobility promotes the transmission of infectious disease agents.48
3.3. Deforestation
Human population growth and over-exploitation of the land,
such as logging, mining, road construction, and agricultural
production, has resulted in deforestation. These changes in turn
cause a cascade of factors that aggravate the emergence of zoonotic
diseases, such as forest fragmentation, population migration,
pathogen introduction, and environmental pollution.52
Deforestation forces wildlife to leave their habitat, increasing
interactions among humans, wildlife, and livestock, and thus the
potential for the transmission of pathogens directly or indirectly to
human beings.53,54 Some zoonotic diseases, including mountain
and desert subtypes of leishmaniasis in western China, Lyme
disease in northern China, and SFTS in central and northeast China
caused by a novel bunyavirus, are related to deforestation, and
humans are infected by the bites of wild vectors, Phlebotomus
chinensis for leishmaniasis, Ixodes persulcatus for Lyme disease, and
Haemaphysalis longicornis for SFTS during agricultural activities on
the land changed from a forest.9,55,56
3.4. Livestock production
Livestock production in China has expanded at an unprece-
dented rate over the past three decades. The consumption of pigsincreased 3.7-fold from 160 million in 1978 to 610 million in 2008,
of cattle increased 1.5-fold from 70 million to 106 million, of sheep
and goats increased 1.65-fold from 170 million to 281 million, and
of poultry increased 7.3-fold from 170 million to 9700 million.57
Large-scale farms and scattered small-scale individual farms
coexist in China, and the latter account for the majority.58 Almost
every household in rural areas is engaged in livestock production,
including pigs, chickens, bovines, sheep, ducks, etc. Different
domestic animals live in the same environment, which provides a
dynamic micro-environment that contributes to interspecies
transmission, even from animals to humans.59,60
Another example is human echinococcosis in Tibetan pastoral
communities in western China, in which dogs, domestic animals
(yaks, sheep, and goats), and wild animals living in the same
environment are involved in the transmission cycle of Echinococcus
granulosus and Echinococcus multilocularis, contributing to the high
prevalence of human echinococcosis.61
Due to the practice of scattered small-scale individual farming
and the lack of meat inspection at such small operations, farmers
often slaughter their animals for their own consumption.
Compared with professionals in modern abattoirs, the local
farmers do not wear protective clothing or gloves, resulting in
high incidences of brucellosis infection in this population and
other livestock-related occupations, such as herdsmen, coat and
leatherworkers, and veterinarians.37 On the other hand, the large-
scale farms, also termed concentrated animal feeding operations
(CAFO), are increasing at an unprecedented rate in China, which
will increase the risk of disease transmission.
Chinese livestock production is also challenged with the threat
of diseases; the use of some antibiotics in animal feed has been
allowed for a long time for the prevention of animal diseases and to
promote animal growth.62 However, the overuse of antibiotics
speeds up the production of drug resistance of bacteria and the
emergence of zoonotic disease. Streptococcus suis is a porcine
pathogen and occasional cause of disease in humans. Human S. suis
outbreaks were reported in 1998 and 2005; they affected 25 and
204 people, and killed 14 and 38 people, respectively.63 The high
mortality rate and high proportion of toxic shock-like syndrome in
these outbreaks were found to be associated with drug resistance
and the rapid evolution of virulence of S. suis serotype 2.64
3.5. Food safety
Food-borne pathogens are also associated with the emergence
and re-emergence of zoonotic diseases. In 2005, 1.8 million people
worldwide died of diarrheal diseases due to contaminated food
and drinking water.65 Although the burden of diseases caused by
food-borne pathogens remains largely unknown in China, there
have been many public health emergencies related to food-borne
pathogens during the past 20 years. For example, a large outbreak
of human angiostrongyliasis occurred in Beijing in 2006, affecting
160 persons.66 From 2004 to 2009, 15 outbreaks of human
trichinellosis occurred in China, resulting to 1387 cases and four
deaths.67 Other important food-borne zoonotic pathogens include
Salmonella spp, Campylobacter spp, Escherichia coli, and hepatitis E
virus.68
Many factors are associated with the emergence and re-
emergence of food-borne zoonotic diseases, including the global
market in meat and farm animals, the habit of eating raw or
undercooked food or wildlife, and the increasingly immunocom-
promised population.65
3.6. Climate change
Global temperatures are rising, and will increase by 1.8–5.8 8C
by the end of the 21st century.69 The annual average temperature
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increase by 1.3–2.1 8C in 2020, and by 2.3–3.3 8C in 2050.70 The
increased temperature can enhance pathogen development,
disease transmission, and host susceptibility.71
Animal and vector-borne diseases are strongly affected by
climate change. Increased temperatures will accelerate the
development of mosquitoes. Since mosquitoes lay their eggs in
water-ﬁlled containers, rainfall often affects larval habitats and
vector populations. In some cases, rainfall may change larval
habitats and vector populations. Excessive rain can remove
habitats through ﬂooding, while limited rainfall may create new
habitats, when water in the rivers is drawn into pools to create
novel breeding sites for a number of mosquito species during the
dry season.69
A typical example is Schistosomiasis japonicum, whose interme-
diate host Oncomelania hupensis is usually limited to areas with a
mean January temperature of above 0 8C. Due to the increasing
temperature, schistosomiasis japonica will be transmitted to non-
endemic areas in the north, and the additional risk area is expected
to be increased by 783 883 km2 by 2050, equivalent to 8.1% of the
surface area of China.72
Waterborne infectious diseases are also strongly affected by
climate change. During times of drought, water scarcity results in
poor sanitation, therefore, many people can be exposed to
potentially contaminated water. In contrast, excess rainfall and
ﬂooding can also cause epidemics of waterborne infectious
diseases, including bacterial and protozoan diarrheal illnesses.73,74
3.7. Pathogen mutation
Changes in natural conditions often lead to genetic evolution of
microorganisms, such as genetic reassortment and recombination,
horizontal transfer of virulence elements, and antimicrobial
resistance, possibly resulting in the transition of microbes from
non-pathogenic to pathogenic, from low virulence to high
virulence, thus causing the emergence of zoonotic diseases.
One example of the effects of genetic reassortment on the
emergence and re-emergence of zoonotic diseases is HPAI H5N1.75
Inﬂuenza A viruses possess a genome of segmented RNA fragments
and genetic reassortment usually happens.76 If a host is co-infected
with two different subtypes of avian inﬂuenza virus, new viral
particles will probably be assembled by genetic reassortment, in
which some gene fragments come from one subtype and some
come from another. This genetic reassortment contributes to
newly emerging pathogens of humans and animals, such as the
recent emergence of the swine-origin inﬂuenza A (H1N1) virus.77
The SARS coronavirus HKU1 (CoV HKU1), isolated from
patients in Hong Kong from 2003 to 2005, was divided into three
clusters: genotypes A, B, and C. However, the phylogenetic
analysis of different genomic regions showed that the nucleotide
sequences of putative proteins (nsp) 4 to nsp6 of the genotype A
strains were clustered with the genotype B strains, while nsp7 and
nsp8 and from nsp10 to nsp16 from the genotype A strains were
clustered with the genotype C strains, suggesting that genetic
recombination between genotypes A and B generated genotype
C.78 This genetic recombination in coronaviruses could easily
generate novel coronavirus genotypes or species that could cross
host species barriers and cause the emergence of major zoonotic
diseases.
S. suis sequence type (ST) 7, in which the tetracycline resistance
gene, tetM, was detected, caused two large outbreaks and sporadic
infections in China.63 S. suis ST7 acquired tetM on the conjugative
transposon Tn916 via horizontal transfer.79 The abuse of tetra-
cyclines on swine farms could have provided the selective pressure
for clone ampliﬁcation and spreading, thus causing the outbreak of
S. suis ST7.4. Control strategies and measures
As in many countries, responsibilities for health issues in
humans, domestic animals, and wild animals in China are
separated into several different ministries and levels of govern-
ment, including the Ministry of Health, Ministry of Agriculture, and
Ministry of Forestry, respectively. In order to respond to these
emerging and re-emerging zoonoses, the Chinese government has
endeavored to enhance the prevention and control of infectious
diseases since the 2003 SARS epidemic.
4.1. Formulation of laws and regulations
The Chinese government has developed and enacted a series of
laws and regulations for the prevention and control of infectious
diseases in humans, domestic animals, and wild animals, such as
the Infectious Diseases Prevention Law of the People’s Republic of
China, Emergency Regulations on Public Health Emergencies,
Major Animal Disease Emergency Ordinance, Animal Epidemic
Prevention Law of the People’s Republic of China, National Sudden
Major Animal Disease Contingency Plans, Terrestrial Wild Animal
Epidemic Sources and Disease Monitoring Standards.80–82 These
laws and regulations deﬁne the responsibilities of governments at
all levels, and help them to report, control, treat, and take other
emergency measures against infectious diseases in humans,
domestic animals, and wild animals.83
4.2. Establishment of the disease reporting systems
The Chinese government has also established disease reporting
systems for humans, domestic animals, and wild animals. In fact, a
routine reporting system for selected infectious diseases in
humans was established in the 1950s.11 Currently the Ministry
of Health has improved the disease reporting system, which was
switched from paper, or electronic ﬁle-based reporting to web-
based reporting. In the past, hospitals and clinics submitted case
reports to their county or district Center of Disease Control and
Prevention (CDC), and subsequently the local CDC submitted the
reports to the National CDC.84 Using the present reporting system,
hospitals and clinics can immediately and directly report cases
through the internet, allowing public health ofﬁcials to have real-
time information on diseases, and decide to enforce any needed
control strategies.1
The Ministry of Forestry has constructed a disease monitoring
and reporting system for wild animals. Currently, China has
established 350 national monitoring stations and 768 provincial,
municipal and county stations or points, which cover the key areas
of activities of the vast majority of migratory birds and has
effectively prevented the spread of avian inﬂuenza by migratory
birds.85 The Ministry of Agriculture has also established a
disease reporting system for domestic animals and cross-border
animals.86
The State Council has stressed the need to enforce cooperation
and information sharing between ministries and between different
levels of government. Therefore, the Chinese government can
respond effectively and efﬁciently when confronted with a disease
crisis.
4.3. Implementation of special projects for major infectious diseases
The Chinese government has carried out a special project for the
prevention and control of major infectious diseases, whose aims
are to reduce the incidence and mortality of AIDS, viral hepatitis,
and tuberculosis, and to improve the emergency response and
capabilities of infectious disease prevention and control. The
project has also focused on the detection of infectious diseases and
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technical support for emergency decisions related to infectious
diseases.87
Based on thematic studies, the laboratory network, common
technology platform, academic union, demonstration areas, and
the effective integration of superior forces, a multi-linked network
technology system has been developed, and the prevention and
control technology support system for infectious diseases has been
established.87 The project has improved the ability to deal with the
traditional infectious diseases and has also contributed to the
signiﬁcantly enhanced emergency response abilities against
emerging zoonotic diseases. For example, in response to the
pandemic caused by a novel swine-origin inﬂuenza A (H1N1) virus
in 2009, an effective and safe vaccine for various age groups was
ﬁrst developed in China, which played an important role in
controlling the inﬂuenza epidemic.88 Another major breakthrough
in the ﬁeld of global etiological research since the discovery of the
SARS coronavirus, is the discovery in 2009 that a novel bunyavirus
had been responsible for a life-threatening illness associated with
fever and thrombocytopenia in China since 2007.9
4.4. Surveillance of exotic diseases
A large number of wild animals, including wild boar, geese,
gazelles, red deer, wild birds, and captive wild zoo animals (canines,
felines, and monkeys) are imported into China from Africa, South
America, Oceania, Asia, and other countries every year.89,90 To
prevent certain exotic diseases that are emerging abroad but are not
found in China, such as bovine spongiform encephalopathy, Ebola
hemorrhagic fever, West Nile fever, and monkeypox, from entering
China, the Chinese government has strengthened surveillance and
control of cross-border transmission of these exotic diseases and
has established the Joint Control Mechanism of Transboundary
Animal Diseases in China and neighboring countries. This includes
the establishment of direct dialogue mechanisms at the national
level, provincial veterinary departments, and animal disease
information sharing platforms, and transboundary animal disease
prevention and control stations.91,92
4.5. Emphasis on interdisciplinary and international cooperation
Recent outbreaks of the emerging HPAI H5N1 and SARS, and the
re-emerging rabies, brucellosis, and other zoonoses in China,
represent examples of interactions among humans, animals, and
their environment that contribute to the presence and spread of
emerging infectious diseases. The rise in emerging and resurging
zoonoses threatens not only human health, but also animal health
and socioeconomic development. The Chinese government has
established interdisciplinary and cross-sector collaborations and
communications among human, animal, and environment health
services, which reﬂect the ‘One Health’ strategy to confront
emerging infectious disease. Moreover, the emphasis should be to
build international early warning systems by international
collaboration and coordination to detect unknown infectious
diseases of international public health importance.93
4.6. Health education
Most emerging and re-emerging zoonotic diseases come from
wildlife. China has 56 ethnic groups with different ways of life and
customs, and some people have a habit of consuming wild animals
and raw meat.94,95 Therefore, healthy eating habits have been
recommended and the consumption of wild animals is prohibited
by legislation. All cutting boards, knives, and other materials
touching uncooked meat should be separated from those used for
cooked meat, and also washed thoroughly with soap and water.96Pets may be another important source of zoonotic diseases in
China, including rabies, toxoplasmosis, and salmonellosis.97,98
Proper care of pets may prevent the transmission of pet-borne
zoonotic diseases to humans, including compulsory vaccination of
pets, keeping pet living areas clean, and washing hands thoroughly
after handling pets.99 The public are educated about the risk factors
associated with wildlife and pets.100,101
5. Conclusions
In the past 10 years, the emergence of SARS, HPAI H5N1, avian
inﬂuenza H7N9, and SFTS, and the re-emergence of rabies,
brucellosis, and other zoonoses, have not only posed a signiﬁcant
national burden on economies and public health in China, but have
also affected other countries. These zoonotic diseases represent
examples of interactions among humans, animals, and their
environment, which continue to have an important impact on
zoonotic diseases, facilitating the emergence of new diseases or the
re-emergence of old ones. The social and natural conditions that
promote the spread of zoonotic diseases include rapid population
growth, increasing population migration due to urbanization,
changes in the habitats of host animals and vectors by deforesta-
tion, backyard animal breeding accompanied by concentrated
animal feeding operations, the global market in meat and farm
animals, the habit of eating raw or undercooked food and wildlife,
and the increasingly immunocompromised individuals.
As no one knows what, when, and where the next novel
zoonoses will emerge, we must be prepared for the unexpected.102
Since the 2003 SARS epidemic, the Chinese government has
devised new strategies and has taken measures to deal with the
emergence and re-emergence of zoonotic diseases, including
issuing laws and regulations for the prevention and control of
infectious diseases of humans, domestic animals, and wild animals,
the establishment of disease reporting systems for humans,
domestic animals, and wild animals, the implementation of special
projects for major infectious diseases to improve the emergency
response and capabilities of infectious diseases prevention and
control, the surveillance of exotic diseases to prevent cross-border
transmission of zoonotic diseases, an emphasis on interdisciplin-
ary and international cooperation according to the ‘One Health’
concept, and proposing a healthy, active lifestyle. These strategies
and measures can serve as models for surveillance and the
response to threats from major emerging and re-emerging
zoonotic diseases in other countries.
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